When turned on, the gene p53 turns off cancer. However, when existing drugs boost p53, only a few tumors die — the rest resist the challenge. A new study shows how: tumors that live even in the face of p53 reactivation create more of the protein p21 t… Continue reading
Share on FacebookMay 22, 2013
by MoreRecycling
0 comments
